Causal association between metabolic syndrome and cholelithiasis: a Mendelian randomization study

Qi Zhu, Yawei Xing, Yunfeng Fu, Xiaqin Chen, Langyi Guan, Foqiang Liao, Xiaodong ZhouFrontiers in Endocrinology 2023 · DOI

TL;DR

Using Mendelian randomization, researchers have established a likely causal link between metabolic syndrome (MetS) and the development of gallstones (cholelithiasis). The study identifies abdominal obesity, measured by waist circumference, as the most significant driver of this increased risk.

What Problem Does This Paper Address?

Metabolic syndrome—a cluster of conditions including abdominal obesity, high blood pressure, high blood sugar, and abnormal cholesterol levels—has long been associated with gallstones in observational studies. However, these studies are often clouded by "confounding factors" like diet, exercise, and socioeconomic status, making it hard to tell if MetS actually causes gallstones or if they just happen to occur in the same people.

The authors set out to determine if a true causal relationship exists. Understanding this is crucial for clinical practice: if MetS is a cause, then managing the syndrome isn't just about heart health—it’s a direct strategy for preventing painful and costly gallbladder disease.

Methods

The researchers employed Mendelian randomization (MR), a method that uses genetic variants (Single Nucleotide Polymorphisms, or SNPs) as "natural" proxies for risk factors. Because these genetic variants are assigned at birth, they aren't affected by the lifestyle factors that usually bias observational research, acting much like a randomized controlled trial.

Key technical aspects included:

  • Two-sample MR: Using one dataset to identify genetic markers for the exposure (MetS) and another for the outcome (cholelithiasis).
  • Statistical Models: They used Inverse Variance Weighting (IVW) as the primary tool, supplemented by MR-Egger regression and the weighted median method to ensure the results weren't being skewed by "pleiotropy" (when one gene affects multiple unrelated traits).
  • Sensitivity Analysis: Tools like Cochran’s Q test and MR-PRESSO were used to detect outliers and ensure the stability of the findings.

Datasets

The study utilized massive, high-quality GWAS (Genome-Wide Association Study) summary data:

  • Metabolic Syndrome: Data from the Complex Trait Genetics Lab (CTG) involving 461,920 individuals of European ancestry.
  • Cholelithiasis: Data from the FinnGen Consortium, including 19,023 cases and 195,144 controls.
  • Components: Individual datasets for fasting blood glucose (FBG), waist circumference (WC), hypertension, and lipids (HDL-C and triglycerides) were sourced from the UK Biobank, the Global Lipids Genetics Consortium (GLGC), and other major repositories.

Key Insights and Ideas

  • The "Abdominal Obesity" Smoking Gun: While the overall metabolic syndrome showed a causal link, the analysis of individual components revealed that waist circumference was the primary culprit. Other factors like blood pressure and fasting glucose did not show a statistically significant causal effect on their own in this model.
  • Mechanistic Link: The authors suggest that obesity increases the secretion of cholesterol into the bile. When bile becomes supersaturated with cholesterol, it crystallizes into gallstones.
  • Genetic vs. Observational: This study reinforces the value of MR. While some observational studies suggested high blood sugar was a major factor, the genetic evidence points more decisively toward fat distribution.

Key Results

  • Metabolic Syndrome: The IVW method showed that MetS significantly increases the risk of gallstones, with an Odds Ratio (OR) of 1.28 (95% CI 1.13–1.46, P < 0.001).
  • Waist Circumference: This was the strongest individual predictor, with an OR of 1.48 (95% CI 1.34–1.65, P < 0.001).
  • Consistency: The weighted median method yielded even higher risk estimates (OR 1.49 for MetS and OR 1.73 for WC), providing further confidence in the direction of the effect.
  • Negative Findings: Fasting blood glucose, hypertension, and triglycerides did not reach the threshold for a causal relationship in this specific analysis.

Limitations and Future Work

  • Ancestry Bias: The study focused almost exclusively on populations of European ancestry. Genetic associations can vary across different ethnic groups, so these results might not be perfectly generalizable to global populations.
  • Gallstone Subtypes: The data did not distinguish between different types of gallstones (e.g., cholesterol stones vs. pigment stones). Since the biological mechanisms differ, future research should look at these subtypes separately.
  • Mediation Pathways: While the study identifies waist circumference as a key driver, the exact biological "middle-man" (e.g., specific hormonal changes or inflammatory markers) remains a target for future investigation.

Summary updated

Abstract

Our study indicated that MetS increases the incidence of cholelithiasis, especially in MetS patients with abdominal obesity. Control and treatment of MetS can effectively reduce the risk of gallstone formation.
BibTeX
@inproceedings{zhu2023causal,
  author = {Qi Zhu and Yawei Xing and Yunfeng Fu and Xiaqin Chen and Langyi Guan and Foqiang Liao and Xiaodong Zhou},
  title = {{Causal association between metabolic syndrome and cholelithiasis: a Mendelian randomization study}},
  booktitle = {Frontiers in Endocrinology},
  year = {2023},
  doi = {10.3389/fendo.2023.1180903},
}
Figure